Ruxolitinib

Lus piav qhia luv luv:

API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas)
Ruxolitinib Myelofibrosis Novartis Lub Xya Hli 6, 2024


Product Detail

Khoom cim npe

KHOOM PLIG

Ruxolitinib yog ib tug me me molecule Janus kinase inhibitor uas yog siv nyob rau hauv kev kho mob ntawm nruab nrab los yog siab myelofibrosis thiab resistant cov ntaub ntawv ntawm polycythemia vera thiab graft-vs-host kab mob. Ruxolitinib cuam tshuam nrog kev ncua sijhawm thiab feem ntau me ntsis nce hauv cov ntshav aminotransferase thaum kho thiab rau qee qhov tsis tshua muaj kev txwv ntawm tus kheej, kev kho mob pom tseeb idiosyncratic mob siab rau lub siab nrog rau cov xwm txheej ntawm reactivation ntawm kab mob siab B hauv cov tib neeg uas raug mob.

Ruxolitinib yog ib qho kev hais lus bioavailable Janus-associated kinase (JAK) inhibitor uas muaj peev xwm antineoplastic thiab immunomodulating kev ua ub no. Ruxolitinib tshwj xeeb khi rau thiab inhibits proteintyrosinekinases JAK 1 thiab 2, uas tuaj yeem ua rau txo qis kev mob thiab inhibition ntawm cellular proliferation. JAK-STAT (lub teeb liab transducer thiab activator ntawm transcription) txoj hauv kev plays lub luag haujlwm tseem ceeb hauv kev taw qhia ntawm ntau yam cytokines thiab kev loj hlob thiab koom nrog hauv cellular proliferation, kev loj hlob, hematopoiesis, thiab kev tiv thaiv kab mob; JAK kinases tej zaum yuav raug kho nyob rau hauv cov kab mob inflammatory, myeloproliferative disorders, thiab ntau yam malignancies.

Ruxolitinib yog ibpyrazolehloov ntawm txoj haujlwm 1 los ntawm 2-cyano-1-cyclopentylethyl pawg thiab ntawm txoj haujlwm 3 los ntawm pyrrolo [2,3-d] pyrimidin-4-yl pawg. Siv los ua cov ntsev phosphate rau kev kho mob ntawm cov neeg mob uas muaj kev pheej hmoo nruab nrab lossis muaj kev pheej hmoo siab myelofibrosis, suav nrog thawj myelofibrosis, post-polycythemia vera myelofibrosis thiab post-tseem ceeb thrombocythemia myelofibrosis. Nws muaj lub luag haujlwm ua tus neeg sawv cev antineoplastic thiab EC 2.7.10.2 (tsis yog cov protein tshwj xeeb-tyrosinekinase) inhibitor. Nws yog nitrile, apyrrolopyrimidinethiab ib tug tswv cuab ntawm pyrazoles.

CERTIFICATE

2018 GMP-2
GMP 201811 (captopril, thalidomide thiab lwm yam)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Tsab Ntawv-201901

QUALITY MANAGEMENT

Kev tswj kom zoo 1

Tswv yim18Quality Consistency Evaluation tej yaam num uas tau pom zoo4, thiab6tej yaam num raug tso cai.

Kev tswj kom zoo 2

Advanced thoob ntiaj teb kev tswj hwm qhov system tau tso lub hauv paus ruaj khov rau kev muag khoom.

Kev tswj kom zoo 3

Kev saib xyuas zoo khiav los ntawm tag nrho lub neej voj voog ntawm cov khoom kom ntseeg tau tias qhov zoo thiab kho cov nyhuv.

Kev tswj kom zoo 4

Pab Pawg Kev Tswj Xyuas Kev Tswj Xyuas Kev Ua Haujlwm txhawb nqa qhov kev xav tau zoo thaum lub sijhawm thov thiab sau npe.

PRODUCTION MANAGEMENT

cpf5 ua
cpf6 ua

Kauslim Countec Lub raj mis ntim kab

cpf7 ua
cpf8 ua

Taiwan CVC Lub raj mis ntim kab

cpf9 ua
cpf 10

Ltalis CAM Board Ntim Kab

cpf 11

German Fette Compacting Tshuab

cpf12 ua

Nyiv Viswill Tablet Detector

cpf14-1

DCS Control Room

PARTNER

Kev koom tes thoob ntiaj teb
Kev koom tes thoob ntiaj teb
Kev koom tes hauv tsev
Kev koom tes hauv tsev

  • Yav dhau los:
  • Tom ntej:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb